Minimal Increase in contrast enhancement after chemo-radiotherapy (CRT) for
glioblastoma predicts worse survival and progression-free survival
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Purpose/Objectives
• Assessment of treatment response
and progression is suboptimal in
glioblastoma (GBM).
• In the context of pseudo-progression,
radiographic change is a challenging
parameter to assess.
• Based on unpublished data from
Gzell et. al., a novel method for
measurement
of
contrast
enhancement demonstrates promise
in predicting survival.
• We aim to determine if early
measurement of radiographic change
post-CRT using multiple methods is
predictive for overall survival (OS)
and progression free survival (PFS).
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Results

Figure 2: 3 Month
RIM +/-25% PFS

Figure 1: 3 Month
RIM +/-25% OS

Figure 5: Volumetric Technique

Post-operative post-CRT T1 + C MRI. Volumetric technique
contours surgical resection cavity. (highlighted in RED).

Figure 6: Rim Technique
Figure 4: 1 month RIM
+/- 5% PFS

Figure 3: 1 Month RIM +/5% OS

Methods
• Patients with primary GBM who
received CRT between 2007-14 and
had sequential post-CRT gadoliumenhanced T1 weighted (T1+C) MRIs
post-operatively, at 1 month, and 3
months within our PACS were
identified.
• Inclusion criteria for analysis:
initiation
of
concurrent
CRT,
presence of 1 and 3 month post-CRT
T1+C MRIs, absence of clinical or
radiographic progression by 3
months post-CRT, and no treatment
with bevacuzimab prior to 3 months
post-CRT.
• 29/97 eligible patients T+1 C MRIs
were subsequently imported into
Pinnacle for analysis.
• We quantified bi-directional product
(BP), volume of the post-surgical
cavity
including
surrounding
enhancement (Vol), and volume of
T1+C enhanced rim (Rim) with the
cavity subtracted.
• We sought to determine if increases
of 5% and/or 25% between PO and
1 or 3 month T1+C MRI’s were
predictive of worse OS and PFS for
each technique.

Post-operative post-CRT T1+ C MRI. Rim technique
contours contrast enhancement (highlighted in GREEN).

Figure 7: BP Technique

Table 1: Overall Survival (Months)

RIM <5%

>5%

P1

<25%

>25%

P2

M+1 26.9 15.23

0.010

26.9

13.87

0.001

M+3 26.9 16.77

0.016

31.3

15.23

0.001

Post-operative post-CRT T1+ C MRI. BP technique
marks measures volume cavity with the largest x and
y axis.

Conclusions
Table 2: Progression Free Survival (Months)

RIM

< 5%

>5%

P1

<25%

>25%

P2

M+1

12.0

14.9

0.127

14.93

11.70

0.015

M+3

12.2

9.33

0.203

15.50 10.030 0.011

• Even minor change in the relative amount of
enhancement surrounding the post-surgical cavity
is an early prognostic factor for OS and PFS.
Changes of Vol or BP were not significant
predictors of OS. These findings suggest that
either
a
lack
of
early
response
or
underappreciated
progression
portends
a
significantly worse prognosis and raises the
question of whether salvage therapies should be
considered earlier in these patients.

